These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10496192)

  • 21. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    Feldman AM; Baughman KL; Lee WK; Gottlieb SH; Weiss JL; Becker LC; Strobeck JE
    Am J Cardiol; 1991 Nov; 68(11):1203-10. PubMed ID: 1951080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies.
    Bertolet BD
    Drug Saf; 2004; 27 Suppl 1():11-8. PubMed ID: 15293849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inotropic therapy for heart failure.
    Stevenson LW
    N Engl J Med; 1998 Dec; 339(25):1848-50. PubMed ID: 9854124
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential response to vesnarinone by cardiac fibroblasts isolated from normal and aortic regurgitant hearts.
    Ross JS; Goldfine SM; Herrold EM; Borer JS
    Am J Ther; 1998 Nov; 5(6):369-75. PubMed ID: 10099079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesnarinone-mediated alterations of gene expression in cardiac fibroblasts from aortic regurgitant hearts.
    Truter SL; Dumlao TF; Lee JA; Lee E; Supino PG; Borer JS
    Am J Ther; 2004; 11(5):328-36. PubMed ID: 15356428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis.
    Uetrecht JP; Zahid N; Whitfield D
    J Pharmacol Exp Ther; 1994 Sep; 270(3):865-72. PubMed ID: 7932198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of OPC-8212, an inotropic agent, in patients with chronic congestive heart failure--a multiple dose evaluation on its effect and arrhythmogenesis].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Oct; 36(10):1125-31. PubMed ID: 3247528
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on digoxin and other oral positive inotropic agents for chronic heart failure.
    Reddy S; Benatar D; Gheorghiade M
    Curr Opin Cardiol; 1997 May; 12(3):233-41. PubMed ID: 9243080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of positive inotropic agents for chronic heart failure: how have we gone astray?
    Packer M
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):119A-126A. PubMed ID: 8397231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment.
    Inoue M; Hori M; Yasuda H; Takishima T; Sugimoto T; Sasayama S; Sakurai T; Nonogi H; Kodama K; Kusukawa R
    Cardiovasc Drugs Ther; 1987 Aug; 1(2):169-75. PubMed ID: 3154320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
    Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
    Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vesnarinone for heart failure.
    Schwartz A; Grupp I; Grupp G
    N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line.
    Shioi T; Matsumori A; Matsui S; Sasayama S
    Life Sci; 1994; 54(1):PL11-6. PubMed ID: 8255163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
    LeJemtel TH
    Curr Cardiol Rep; 1999 May; 1(1):31. PubMed ID: 10980817
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
    Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
    Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vesnarinone, a novel orally active inotropic agent with an immunosuppressive action, on experimental cardiac transplantation in rats.
    Yokoyama H; Momeni R; Goldstein C; Mohiuddin M; Shen Z; Fyfe BS; Whitman GJ; DiSesa VJ
    Transplantation; 1996 Dec; 62(11):1540-3. PubMed ID: 8970604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.